FHTX
Foghorn Therapeutics
$2.13
+$0.08 (+3.9%)Oct 28, 2026
Key metrics
The numbers that frame FHTX today
- Market cap
- $126.49M
- Gross margin
- 100%
- EV / Sales
- 2.7
- ROIC
- -68%
- Div yield
- 0%
- 52wk Low
- $1.79
- 52wk High
- $7.61
Growth
Revenue and earnings trend for FHTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about FHTX
Is Foghorn Therapeutics a good buy?
No. Foghorn Therapeutics has weak quality and poor momentum. Both signals point to a weaker setup. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Foghorn Therapeutics is selling at a very high price.
What is the market capitalization of FHTX?
Foghorn Therapeutics's market capitalization is $126.49M.
What is the 52-week high for FHTX stock?
The 52-week high for Foghorn Therapeutics is $7.61. The current close of $2.13 is 72% below that high.
What is the 52-week low for FHTX stock?
The 52-week low for Foghorn Therapeutics is $1.79. The current close of $2.13 is 19% above that low.
Does FHTX stock pay dividends?
Foghorn Therapeutics does not currently show a dividend per share in the company data.